University of California (San Diego) Medical Center Neuromuscular Medicine (Neurology)

Topics

• Amyotrophic Lateral Sclerosis Research 96
• Obstructive Sleep Apnea Research 54
• Glioma Diagnosis and Treatment 23
• Muscle Physiology and Disorders 12
• Neurogenetic and Muscular Disorders Research 10
• Respiratory Support and Mechanisms 10
• Myasthenia Gravis and Thymoma 8
• Neuroscience of respiration and sleep 6
• Sarcoma Diagnosis and Treatment 6
• Botulinum Toxin and Related Neurological Disorders 5
• Cardiomyopathy and Myosin Studies 4
• Cardiovascular and Diving-Related Complications 4

Most cited

1. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.

   JAMA · 2024 · 170 citations · Gregory Sahagian

2. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.

   The Lancet. Neurology · 2023 · 236 citations · Gregory Sahagian

3. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

   The Lancet. Neurology · 2024 · 113 citations · Chamindra Laverty

4. Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics.

   The Lancet. Neurology · 2025 · 36 citations · John Ravits

5. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study.

   The Lancet. Neurology · 2024 · 71 citations · John Ravits

6. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition.

   Nature cell biology · 2022 · 137 citations ·